
Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

